Baxter International Inc. (BAX)

Last Price:  

Company Description

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $11.67B
Net Income (Most Recent Fiscal Year) $1.10B
PE Ratio (Current Year Earnings Estimate) 23.31
PE Ratio (Trailing 12 Months) 25.80
PEG Ratio (Long Term Growth Estimate) 2.33
Price to Sales Ratio (Trailing 12 Months) 3.37
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 4.82
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 17.06
Pre-Tax Margin (Trailing 12 Months) 11.22%
Net Margin (Trailing 12 Months) 9.18%
Return on Equity (Trailing 12 Months) 19.07%
Return on Assets (Trailing 12 Months) 8.27%
Current Ratio (Most Recent Fiscal Quarter) 2.39
Quick Ratio (Most Recent Fiscal Quarter) 1.78
Debt to Common Equity (Most Recent Fiscal Quarter) 0.67
Inventory Turnover (Trailing 12 Months) 3.72
Book Value per Share (Most Recent Fiscal Quarter) $17.28
Earnings per Share (Most Recent Fiscal Quarter) $0.80
Earnings per Share (Most Recent Fiscal Year) $3.09
Diluted Earnings per Share (Trailing 12 Months) $2.19
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 499.91M
Free Float 498.96M
Market Capitalization $41.14B
Average Volume (Last 20 Days) 3.96M
Beta (Past 60 Months) 0.66
Percentage Held By Insiders (Latest Annual Proxy Report) 0.19%
Percentage Held By Institutions (Latest 13F Reports) 84.04%
Annual Dividend (Based on Last Quarter) $1.12
Dividend Yield (Based on Last Quarter) 1.36%